ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies

Launched by FUDAN UNIVERSITY · Feb 10, 2020

Keywords

ClinConnect Summary

This clinical trial, titled "ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies," is focused on understanding how certain genes may make individuals more likely to develop breast cancer. The researchers are particularly interested in specific genes, like BRCA1, BRCA2, PTEN, CHEK2, and PALB2. They are conducting this study in community health centers and are inviting breast cancer patients to participate voluntarily.

If you or someone you know has been diagnosed with breast cancer, you may be eligible to join this study, regardless of your age or gender. To participate, you will need to provide consent and agree to follow the study's procedures. During the trial, participants will undergo tests to analyze their genetic makeup, which may help researchers learn more about breast cancer risk factors. It’s important to note that this study is not open to healthy individuals or those with other types of cancer. If you're interested in participating or want more information, feel free to reach out to your local community health service center.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • breast cancer patients of any age;
• • both male and female;
• • the subjects signed the informed consent to participate in the study and abide by the study procedure before being selected.
• Exclusion Criteria:
• • healthy people or other malignant tumor patients without breast cancer;
• • unable to interview the investigator and sign the informed consent due to any reason;
• • it is impossible to collect peripheral blood or oral mucosa samples for any reason.